A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus

References

• WeiMGaskillSPHaffnerSMSternMPEffects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart StudyDiabetes Care1998217116711729653614
   PubMed Web of Science ®Google Scholar
• HaffnerSMLehtoSRönnemaaTPyöräläKLaaksoMMortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarctionN Engl J Med199833942292349673301
   PubMed Web of Science ®Google Scholar
• HegdeSSMalleshPYeliSMGadadVMGPMComparative angiographic profile in diabetic and non-diabetic patients with acute coronary syndromeJ Clin Diagn Res201489MC07MC10
   PubMedGoogle Scholar
• TousoulisDKampoliAMStefanadisCDiabetes mellitus and vascular endothelial dysfunction: current perspectivesCurr Vasc Pharmacol2012101193222112354
   PubMed Web of Science ®Google Scholar
• KruthHSLipoprotein cholesterol and atherosclerosisCurr Mol Med20011663365311899253
   PubMedGoogle Scholar
• CroceKLibbyPIntertwining of thrombosis and inflammation in atherosclerosisCurr Opin Hematol2007141556117133101
   PubMed Web of Science ®Google Scholar
• KampoliAMTousoulisDBriasoulisALatsiosGPapageorgiouNStefanadisCPotential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitusCurr Pharm Des201117374147415822204375
   PubMed Web of Science ®Google Scholar
• DerosaGD’AngeloASalvadeoSAModification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjectsMicrovasc Res201079214414920079360
   PubMed Web of Science ®Google Scholar
• DerosaGD’AngeloASalvadeoSAOral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patientsHorm Metab Res201042181319735057
   PubMed Web of Science ®Google Scholar
• BansalTCGuayATJacobsonJWoodsBONestoRWIncidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunctionJ Sex Med20052196103
   PubMed Web of Science ®Google Scholar
• ZitzmannMTestosterone deficiency, insulin resistance and the metabolic syndromeNat Rev Endocrinol200951267368119859074
   PubMed Web of Science ®Google Scholar
• DerosaGFerrariID’AngeloAOral fat load effects on inflammation and endothelial stress markers in healthy subjectsHeart Vessels200924320421019466522
   PubMed Web of Science ®Google Scholar
• DerosaGFerrariID’AngeloAEffects of a standardized oral fat load on vascular remodeling markers in healthy subjectsMicrovasc Res201080111011520359487
   PubMed Web of Science ®Google Scholar
• DavignonJGanzPRole of endothelial dysfunction in atherosclerosisCirculation200410923 suppl 1III27III3215198963
   PubMed Web of Science ®Google Scholar
• NygårdONordrehaugJERefsumHUelandPMFarstadMVollsetSEPlasma homocysteine levels and mortality in patients with coronary artery diseaseN Engl J Med199733742302369227928
   PubMed Web of Science ®Google Scholar
• HossainGSvan ThienenJVWerstuckGHTDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemiaJ Biol Chem200327832303173032712738777
   PubMed Web of Science ®Google Scholar
• StarkebaumGHarlanJMEndothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteineJ Clin Invest1986774137013763514679
   PubMed Web of Science ®Google Scholar
• LazzeriniPESelviELorenziniSHomocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patientsClin Exp Rheumatol200624438739316956428
   PubMed Web of Science ®Google Scholar
• DinneenSFGersteinHCThe association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literatureArch Intern Med199715713141314189224218
   PubMed Web of Science ®Google Scholar
• JagerAKostensePJRuhéHGMicroalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn StudyArterioscler Thromb Vasc Biol199919361762410073965
   PubMed Web of Science ®Google Scholar
• StehouwerCDSmuldersYMMicroalbuminuria and risk for cardiovascular disease: analysis of potential mechanismsJ Am Soc Nephrol20061782106211116825333
   PubMed Web of Science ®Google Scholar
• HameedIMasoodiSRMirSANabiMGhazanfarKGanaiBAType 2 diabetes mellitus: from a metabolic disorder to an inflammatory conditionWorld J Diabetes20156459861225987957
   PubMed Web of Science ®Google Scholar
• PopaCNeteaMGvan RielPLvan der MeerJWStalenhoefAFThe role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular riskJ Lipid Res200748475176217202130
   PubMed Web of Science ®Google Scholar
• KullerLHTracyRPShatenJMeilahnENRelation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention TrialAm J Epidemiol199614465375478797513
   PubMed Web of Science ®Google Scholar
• RockKLKonoHThe inflammatory response to cell deathAnnu Rev Pathol200839912618039143
   PubMed Web of Science ®Google Scholar
• RashidinejadHHosseiniSMMoazenzadehMRelationship between serum level of high-sensitive C-reactive protein and extension of myocardial involvement in patients with acute myocardial infarctionRom J Intern Med201250321121523330288
   PubMedGoogle Scholar
• AruomaOIFree radicals, oxidative stress, and antioxidants in human health and diseaseJ Am Oil Chem Soc199875199212
   PubMed Web of Science ®Google Scholar
• FuXKassimSYParksWCHeineckeJWHypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidaseJ Biol Chem200127644412794128711533038
   PubMed Web of Science ®Google Scholar
• BaldusSHeitzerTEiserichJPMyeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusionFree Radic Biol Med200437690291115304260
   PubMed Web of Science ®Google Scholar
• NauseefWMContributions of myeloperoxidase to proinflamma-tory events: more than an antimicrobial systemInt J Hematol200174212513311594511
   PubMed Web of Science ®Google Scholar
• PapanicolaouDAWilderRLManolagasSCChrousosGPThe pathophysiologic roles of interleukin-6 in human diseaseAnn Intern Med199812821271379441573
   PubMed Web of Science ®Google Scholar
• HeinrichPCCastellJVAndusTInterleukin-6 and the acute phase responseBiochem J199026536216361689567
   PubMed Web of Science ®Google Scholar
• AharoniSAviramMFuhrmanBParaoxonase 1 (PON1) reduces macrophage inflammatory responsesAtherosclerosis2013228235336123582715
   PubMed Web of Science ®Google Scholar
• AbbottCAMacknessMIKumarSBoultonAJDurringtonPNSerum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteinsArterioscler Thromb Vasc Biol19951511181218187583560
   PubMed Web of Science ®Google Scholar
• IkedaYSuehiroTInoueMSerum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitusMetabolism19984755986029591753
   PubMed Web of Science ®Google Scholar
• SinghRBMengiSAXuYJArnejaASDhallaNSPathogenesis of atherosclerosis: a multifactorial processExp Clin Cardiol200271405319644578
   PubMedGoogle Scholar
• TangYJiangHBryanNSNitrite and nitrate: cardiovascular risk-benefit and metabolic effectCurr Opin Lipidol2011221111521102328
   PubMed Web of Science ®Google Scholar
• BouchieJLHansenHFeenerEPNatriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen systemArterioscler Thromb Vasc Biol19981811177117799812917
   PubMed Web of Science ®Google Scholar
• PannacciulliNDe MitrioVMarinoRGiorginoRDe PergolaGEffect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjectsObes Res200210871772512181379
   PubMedGoogle Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med199934021151269887164
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHBuringJERifaiNC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med20003421283684310733371
   PubMed Web of Science ®Google Scholar
• Porsch-OezçueruemezMKunzDKloerHULuleyCEvaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart diseaseJ Am Coll Cardiol19993471995200110588215
   PubMed Web of Science ®Google Scholar
• de LemosJAHennekensCHRidkerPMPlasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskJ Am Coll Cardiol200036242342610933352
   PubMed Web of Science ®Google Scholar
• ThorandBBaumertJDöringAAssociation of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg StudyThromb Haemost200695113414116543972
   PubMed Web of Science ®Google Scholar
• LiuPSunMSaderSMatrix metalloproteinases in cardiovascular diseaseCan J Cardiol200622suppl B25B30B
   PubMed Web of Science ®Google Scholar
• GibbonsGHDzauVJThe emerging concept of vascular remodelingN Engl J Med199433020143114388159199
   PubMed Web of Science ®Google Scholar
• LongoGMXiongWGreinerTCZhaoYFiottiNBaxterBTMatrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysmsJ Clin Invest2002110562563212208863
   PubMed Web of Science ®Google Scholar
• DerosaGFerrariID’AngeloAMatrix metalloproteinase-2 and -9 levels in obese patientsEndothelium200815421922418663625
   PubMed Web of Science ®Google Scholar
• DerosaGD’AngeloACiccarelliLMatrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertensionEndothelium200613322723116840178
   PubMed Web of Science ®Google Scholar
• DerosaGD’AngeloATinelliCEvaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjectsDiabetes Metab200733212913417320450
   PubMed Web of Science ®Google Scholar
• DerosaGCiceroAFScaliseFMetalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromesEndothelium2007141455117364896
   PubMed Web of Science ®Google Scholar
• DerosaGCiceroAFScaliseFMetalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 monthsEndothelium2007144–517518317922333
   PubMed Web of Science ®Google Scholar
• DerosaGD’AngeloAScaliseFComparison between metal-loproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndromeHeart Vessels200722636137018043992
   PubMed Web of Science ®Google Scholar
• BlankenbergSRupprechtHJPoirierOPlasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular diseaseCirculation2003107121579158512668489
   PubMed Web of Science ®Google Scholar
• MontanerJMolinaCAMonasterioJMatrix metalloproteinase-9 pretreatment levels predicts intracranial hemorrhagic complications after thrombolysis in human strokeCirculation2003107459860312566373
   PubMed Web of Science ®Google Scholar